Effect of furosemide infusion on renal hemodynamics and angiogenesis gene expression in acute renal ischemia/reperfusion

Renal Failure

Volumn 28, Issue 1, 2006, Pages 25-35

  Aravindan, Natarajan ^a,b   Shaw, Andrew ^a  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

Angiogenesis; Corticomedullary tissue oxygen tension; Furosemide; Gene expression; Ischemia reperfusion; Renal hemodynamics

Indexed keywords

FUROSEMIDE; URETHAN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; AREA UNDER THE CURVE; ARTICLE; CALCULATION; CONTROLLED STUDY; DRUG EFFECT; GENE EXPRESSION; KIDNEY BLOOD FLOW; KIDNEY ISCHEMIA; MALE; MOUSE; MULTIVARIATE ANALYSIS OF COVARIANCE; NONHUMAN; POST HOC ANALYSIS; PRIORITY JOURNAL; RAT; RENAL ARTERY; REPERFUSION; SHAM FEEDING; STATISTICAL SIGNIFICANCE;

ACUTE DISEASE; ANIMALS; DIURETICS; FUROSEMIDE; GENE EXPRESSION REGULATION; HEMODYNAMIC PROCESSES; KIDNEY; MALE; NEOVASCULARIZATION, PATHOLOGIC; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY;

EID: 32644455466     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.1080/08860220500461229     Document Type: Article

References (54)

1. Brady HR, Brenner BM, Clarkson MR, Lieberthal W. Acute renal failure. In: Brenner BM, ed. The Kidney. 6th ed. Philadelphia: W.B. Saunders; 2000:1201-1262.
2. Thadhani R, Pascual M, Bonventre JV. Acute renal failure. N Engl J Med. 1996;334:1448-1460.
3. Ashworth SL, Molitoris BA. Pathophysiology and functional significance of apical membrane disruption during ischemia. Curr Opin Nephrol Hypertens. 1999;8:449-458.
4. Cosentino F. Drugs for the prevention and treatment of acute renal failure. Cleve Clin J Med. 1995;62:248-253.
5. Dishart MK, Kellum JA. An evaluation of pharmacological strategies for the prevention and treatment of acute renal failure. Drugs. 2000;59:79-91.
6. Nuutinen LS, Kairaluoma M, Tuononen S, Larmi TK. The effect of furosemide on renal function in open heart surgery. J Cardiovasc Surg (Torino). 1978;19:471-479.
7. Nuutinen LS, Tuononen S. The effect of furosemide on renal blood flow and renal tissue oxygen tension in dogs. Ann Chir Gynaecol. 1976;65:272-276.
8. Dobrowolski L, Sadowski J. Differential effect of furosemide on renal medullary and cortical blood flow in the anaesthetised rat. Exp Physiol. 2000;85:783-789.
9. Katayama S, Attallah AA, Stahl RA, Bloch DL, Lee JB. Mechanism of furosemide-induced natriuresis by direct stimulation of renal prostaglandin E2. Am J Physiol. 1984;247:F555-561.
10. Bayati A, Nygren K, Kallskog O, Wolgast M. The effect of loop diuretics on the long-term outcome of post-ischaemic acute renal failure in the rat. Acta Physiol Scand. 1990;139:271-279.
11. Burke TJ, Malhotra D, Shapiro JI. Effects of enhanced oxygen release from hemoglobin by RSR13 in an acute renal failure model. Kidney Int. 2001;60:1407-1414.
12. Schetz M. Diuretics in acute renal failure? Contrib Nephrol. 2004;144:166-181.
13. de Rougemont D, Oeschger A, Konrad L, et al. Gentamicin-induced acute renal failure in the rat. Effect of dehydration, DOCA-saline and furosemide. Nephron. 1981;29:176-184.
14. De Torrente A, Miller PD, Cronin RE, Paulsin PE, Erickson AL, Schrier RW. Effects of furosemide and acetylcholine in norepinephrine-induced acute renal failure. Am J Physiol. 1978;235:F131-136.
15. Patak RV, Fadem SZ, Lifschitz MD, Stein JH. Study of factors which modify the development of norepinephrine-induced acute renal failure in the dog. Kidney Int. 1979;15:227-237.
16. Kramer HJ, Schuurmann J, Wassermann C, Dusing R. Prostaglandin- independent protection by furosemide from oliguric ischemic renal failure in conscious rats. Kidney Int. 1980;17:455-464.
17. Hanley MJ, Davidson K. Prior mannitol and furosemide infusion in a model of ischemic acute renal failure. Am J Physiol. 1981;241:F556-564.
18. Sinsteden TD, O'Neil TJ, Hill S, Lifschitz MD, Stein JH. The role of high-energy phosphate in norepinephrine-induced acute renal failure in the dog. Circ Res. 1986;59:93-104.
19. Kim SJ, Lim YT, Kim BS, et al. Mechanism of reduced GFR in rabbits with ischemic acute renal failure. Ren Fail. 2000;22:129-141.
20. Ben-Yosef Y, Lahat N, Shapiro S, Bitterman H, Miller A. Regulation of endothelial matrix metalloproteinase-2 by hypoxia/reoxygenation. Circ Res. 2002;90:784-791.
21. Le Jan S, Amy C, Cazes A, et al. Angiopoietin-like 4 is a proangiogenic factor produced during ischemia and in conventional renal cell carcinoma. Am J Pathol. 2003;162:1521-1528.
22. National Research Council Guide for the Care and Use of Laboratory Animals. Institute of Laboratory Animal Resources, Commission on Life Sciences, National Research Council. Washington, DC: National Academy Press; 1996.
23. Liss P, Nygren A, Erikson U, Ulfendahl HR. Injection of low and iso-osmolar contrast medium decreases oxygen tension in the renal medulla. Kidney Int. 1998;53:698-702.
24. Maas W, de Graaf I, Schoen E, Koster H, Van de Sandt J, Groten JP. Assessment of some critical factors in the freezing technique for the cryopreservation of precision-cut rat liver slices. Cryobiology. 2000;40:250-263.
25. Aravindan N, Mohan N, Andrew DS. Fenoldopam inhibits nuclear translocation of nuclear factor kappa B in a rat model of ischemic acute renal failure. J Cardiothorac Vasc Anesth. 2006; (accepted in press).
26. Hierholzer C, Kelly E, Tsukada K, et al. Hemorrhagic shock induces G-CSF expression in bronchial epithelium. Am J Physiol. 1997;273:L1058-1064.
27. Taniguchi A, Tajima T, Nonomura K, Shinohara N, Mikami A, Koyanagi T. Expression of vascular endothelial growth factor and its receptors Flk-1 and Fit-1 during the regeneration of autotransplanted adrenal cortex in the adrenalectomized rat. J Urol. 2004;171:2445-2449.
28. Gonzalez-Parra S, Rosato RR, Chowen JA, et al. Inverse correlation between insulin-like growth factor (IGF)-binding protein-5 and IGF-I and II during postnatal development of the anterior pituitary gland. Horm Res. 2002;57:10-14.
29. Bayraktutan U, Yang ZK, Shah AM. Selective dysregulation of nitric oxide synthase type 3 in cardiac myocytes but not coronary microvascular endothelial cells of spontaneously hypertensive rat. Cardiovasc Res. 1998;38:719-726.
30. Koh JT, Kim OJ, Park YS, et al. Decreased expressions of thrombospondin 2 in cyclosporin A-induced gingival overgrowth. J Periodontal Res. 2004;39:93-100.
31. Penschow JD, Coghlan JP. Furosemide treatment alters the distribution of kallikrein gene expression in kidneys of mice. Exp Nephrol. 1995;3:280-287.
32. Prasad PV, Edelman RR, Epstein FH. Noninvasive evaluation of intrarenal oxygenation with BOLD MRI. Circulation. 1996;94:3271-3275.
33. Baek SM, Brown RS, Shoemaker WC. Early prediction of acute renal failure and recovery. II. Renal function response to furosemide. Ann Surg. 1973;178:605-608.
34. Birtch AG, Zakheim RM, Jones LG, Barger AC. Redistribution of renal blood flow produced by furosemide and ethacrynic acid. Circ Res. 1967;21:869-878.
35. Vetterlein F, Petho A, Schmidt G. Distribution of capillary blood flow in rat kidney during postischemic renal failure. Am J Physiol. 1986;251:H510-519.
36. Yamamoto T, Tada T, Brodsky SV, et al. Intravital videomicroscopy of peritubular capillaries in renal ischemia. Am J Physiol Renal Physiol. 2002;282:F1150-1155.
37. Cantarovich F, Galli C, Benedetti L, et al. High dose furosemide in established acute renal failure. Br Med J. 1973;4:449-450.
38. Reubi FC. Clinical use of furosemide. Ann N Y Acad Sci. 1966;139:433-442.
39. Brezis M, Rosen S, Silva P, Epstein FH. Renal ischemia: a new perspective. Kidney Int. 1984;26:375-383.
40. Heyman SN, Rosen S, Epstein FH, Spokes K, Brezis ML. Loop diuretics reduce hypoxic damage to proximal tubules of the isolated perfused rat kidney. Kidney Int. 1994;45:981-985.
41. Brezis M, Agmon Y, Epstein FH. Determinants of intrarenal oxygenation. I. Effects of diuretics. Am J Physiol. 1994;267:F1059-1062.
42. Ray PS, Estrada-Hernandez T, Sasaki H, Zhu L, Maulik N. Early effects of hypoxia/reoxygenation on VEGF, ang-1, ang-2 and their receptors in the rat myocardium: implications for myocardial angiogenesis. Mol Cell Biochem. 2000;213:145-153.
43. Lobov IB, Brooks PC, Lang RA. Angiopoietin-2 displays VEGF-dependent modulation of capillary structure and endothelial cell survival in vivo. Proc Natl Acad Sci USA. 2002;99:11205-11210.
44. Iwanaga K, Takano H, Ohtsuka M, et al. Effects of G-CSF on cardiac remodeling after acute myocardial infarction in swine. Biochem Biophys Res Commun. 2004; 325:1353-1359.
45. Holder N, Klein R. Eph receptors and ephrins: effectors of morphogenesis. Development. 1999;126:2033-2044.
46. Wang HU, Chen ZF, Anderson DJ. Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4. Cell. 1998;93:741-753.
47. Kasahara H, Tanaka E, Fukuyama N, et al. Biodegradable gelatin hydrogel potentiates the angiogenic effect of fibroblast growth factor 4 plasmid in rabbit hindlimb ischemia. J Am Coll Cardiol. 2003;41:1056-1062.
48. Justicia C, Planas AM. Transforming growth factor-alpha acting at the epidermal growth factor receptor reduces infarct volume after permanent middle cerebral artery occlusion in rats. J Cereb Blood Flow Metab. 1999;19:128-132.
49. Crawford SE, Stellmach V, Murphy-Ullrich JE, et al. Thrombospondin-1 is a major activator of TGF-beta1 in vivo. Cell. 1998;93:1159-1170.
50. Yang YL, Chuang LY, Guh JY, et al. Thrombospondin-1 mediates distal tubule hypertrophy induced by glycated albumin. Biochem J. 2004;379:89-97.
51. Hochegger K, Knight S, Hugo C, et al. Role of thrombospondin-1 in the autologous phase of an accelerated model of anti-glomerular basement membrane glomerulonephritis. Nephron Exp Nephrol. 2004;96:e31-38.
52. Daniel C, Wiede J, Krutzsch HC, et al. Thrombospondin-1 is a major activator of TGF-beta in fibrotic renal disease in the rat in vivo. Kidney Int. 2004;65:459-468.
53. Hugo C, Kang DH, Johnson RJ. Sustained expression of thrombospondin-1 is associated with the development of glomerular and tubulointerstitial fibrosis in the remnant kidney model. Nephron. 2002;90:460-470.
54. Ferrara N. Role of vascular endothelial growth factor in the regulation of angiogenesis. Kidney Int. 1999;56:794-814.